Newronika Overview

  • Founded
  • 2008

Founded
  • Status
  • Private

  • Employees
  • 16

Employees
  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 7

Newronika General Information

Description

Manufacturer of a neuro-modulation device intended to restore brain and body functioning. The company's therapeutic device uses the retro-activity system to record brain activity and modulate neuro-stimulation to collect, analyze and interpret bio-signals, enabling patients to receive the right stimulation at the right moment to perform normal daily activities and improve their quality of life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
  • Via Dante 4
  • 20121 Milan
  • Italy
+39 02 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Newronika Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 000.00 Completed Generating Revenue
3. Later Stage VC (Series A) 25-Sep-2019 00.00 000.00 Completed Generating Revenue
2. Later Stage VC 14-Jun-2016 $1.91M $1.91M Completed Generating Revenue
1. Angel (individual) 01-Jan-2008 Completed Startup
To view Newronika’s complete valuation and funding history, request access »

Newronika Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Manufacturer of a neuro-modulation device intended to restore brain and body functioning. The company's therapeutic devi
Therapeutic Devices
Milan, Italy
16 As of 2021
000.00
000000 - 000 000.00

0000 0

aboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate
00000000000 0000000
San Mateo, CA
000 As of 0000
00000
0000 0000-00-00
00000000000 00000

000000

sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis no
00000000000 0000000
Austin, TX
00 As of 0000
00000
0000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Newronika Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cala Health Venture Capital-Backed San Mateo, CA 000 00000 00000000000 00000
0000000000000000 Venture Capital-Backed Austin, TX 00 00000 00000000000 00000
00000 000000000000 Private Equity-Backed Lausanne, Switzerland 00 000.00 0000000 0000 000.00
000000 Venture Capital-Backed Baltimore, MD 000.00 00000000000 000.00
000000 0000000 000 Venture Capital-Backed Brooklyn, NY 00 00.00 000000000000 00.00
You’re viewing 5 of 13 competitors. Get the full list »

Newronika Patents

Newronika Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220016415-A1 Systems and methods for adaptive deep brain stimulation Pending 17-Jul-2020 0000000000
US-11318309-B2 Method and apparatus for treating tourette syndrome by brain stimulation Active 13-Dec-2018 00000000000 00
US-20200188675-A1 Method and apparatus for treating tourette syndrome by brain stimulation Active 13-Dec-2018 00000000000
AU-2019224826-A2 Apparatus for treating neurological disorders by electro-stimulation and method for processing neural signals collected by the said apparatus Pending 22-Feb-2018 00000000000
CA-3092001-A1 Apparatus for treating neurological disorders by electro-stimulation and method for processing neural signals collected by the said apparatus Pending 22-Feb-2018 A61N1/36067
To view Newronika’s complete patent history, request access »

Newronika Executive Team (6)

Name Title Board Seat Contact Info
Lothar Krinke Ph.D Chief Executive Officer & Board Member
Fabio Grisoni Chief Strategic Officer
Lorenzo Rossi Ph.D Co-Founder, Co-Chief Executive Officer, Board Member & Chief Technology Officer
Alberto Priori Ph.D Chairman of Scientific Advisory Board
You’re viewing 4 of 6 executive team members. Get the full list »

Newronika Board Members (10)

Name Representing Role Since
Alberto Priori Ph.D Newronika Chairman of Scientific Advisory Board 000 0000
Carlo Sanfilippo Self Board Member 000 0000
Claire Poulard Omnes Capital Board Member 000 0000
Claudio Giuliano Innogest Capital Board Member 000 0000
Lorenzo Rossi Ph.D Newronika Co-Founder, Co-Chief Executive Officer, Board Member & Chief Technology Officer 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Newronika Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Newronika Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Omnes Capital PE/Buyout Minority 000 0000 000000 0
Wille Finance Family Office Minority 000 0000 000000 0
F3F Venture Capital Minority 000 0000 000000 0
Indaco Venture Partners Venture Capital Minority 000 0000 000000 0
Innogest Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »